448
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
this post was submitted on 09 Dec 2023
448 points (99.3% liked)
Technology
59346 readers
5183 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 1 year ago
MODERATORS
It's tricky because the money, time and opportunity cost gone into development, testing and the approval process are also priced into this. Plus the fact that this needs to not only break even but make some money plus the fact that this won't be relevant for a huge market I think (not sure how prevalent SCD is). So it's an outrageous price but probably not just plucked out of thin air
This is why pharma research should be publicly funded, and the results go directly into public domain. We will save so much money and lives in the long run that way.
The bigger one is to decouple development from manufacturing.
Development should be done on a bounty type system. Both countries and individual groups can put money into bounties.
Once the bounty is claimed, then the drug is effectively free for all to produce. This lets us leverage capitalism to push prices down.
This would reshape drug development from max money, to most needed.
I like this - but would companies that fail (in being second) not get credit for their work? You could imagine the second place actually having a more effective product at the end.
You don't have a yes/no payout. You have a graded payout. E.g. you might have a 1 shot cure pay out the full amount, but a sustained treatment only pay a smaller %. This lets you encourage development of the most effective treatment, not the most profitable. It's currently better to make a condition chronic, and so need treatment for a lifetime, than develop a cure.
You also don't pay out all at once. By spreading it out over sat 10 years. It means it can be adjusted if the company's claims are... less than accurate.